Pure Global
NCT06116838

Transcutaneous Spinal Cord Stimulation in Healthy Adults

Effect of Varying Transcutaneous Spinal Cord Stimulation Parameters and Location on Lower Extremity Motor Responses and Comfort
Shirley Ryan AbilityLab·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Healthy Adults
Drug/Device/Intervention
Spinal motor evoked responses (sMERs)
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Shirley Ryan AbilityLab
Location
Chicago, United States of America
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2023
End date
Dec 31, 2028
Enrollment
50 participants
Primary outcome

Resting motor threshold,Continuous stimulation tolerance

Summary

The goal of this study is to understand how transcutaneous spinal cord stimulation (tSCS)
 waveform, modulation frequency, and stimulation location impact lower extremity muscle
 activation and participant comfort in adults without neurologic conditions.

ICD-10 classifications
ObesityHealthy person accompanying sick personObesity, unspecifiedRoutine general health check-up of inhabitants of institutionsLifestyle-related condition
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06116838
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06116838 through Pure Global AI's free database. This phase not specified trial is sponsored by Shirley Ryan AbilityLab and is currently Not yet recruiting. The study focuses on Healthy Adults. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.